Pliant Therapeutics (PLRX) Receivables - Other (2019 - 2026)
Pliant Therapeutics (PLRX) posted quarterly Receivables - Other of $914000.0 for Q1 2026, down 45.69% year-over-year from $1.7 million in Q1 2025, and up 11.06% quarter-over-quarter from $823000.0 in Q4 2025.
Pliant Therapeutics (PLRX) Receivables - Other (2019 - 2026) Analysis & Trends
Pliant Therapeutics (PLRX) has reported Receivables - Other for 8 consecutive years, with $914000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Other fell 45.69% year-over-year to $914000.0; the TTM figure through Mar 2026 stood at $914000.0 (down 45.69% YoY), while the FY2025 annual figure was $823000.0, down 64.25% from the prior year.
- Receivables - Other improved to $914000.0 in Q1 2026 per PLRX's latest filing, from $823000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $4.0 million in Q2 2022 and bottomed at $443000.0 in Q1 2022.
- Historically, Receivables - Other has averaged $2.0 million across 5 years, with a median of $2.0 million in 2023.
- Annual changes were most pronounced in 2023 — Receivables - Other jumped 210.84% — and 2025, when it tumbled 64.25%.
- Pliant Therapeutics' Receivables - Other stood at $1.1 million in 2022, then jumped by 178.01% to $3.0 million in 2023, then fell by 23.19% to $2.3 million in 2024, then sank by 64.25% to $823000.0 in 2025, then gained by 11.06% to $914000.0 in 2026.
- Business Quant data shows PLRX's Receivables - Other at $914000.0 in Q1 2026, $823000.0 in Q4 2025, and $908000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Pliant Therapeutics | 70.59 Mn | 70.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 873,000.00 |
| Jun 30, 2026 | 873,000.00 |
| Mar 31, 2026 | 914,000.00 |
| Mar 31, 2026 | 914,000.00 |
| Dec 31, 2025 | 823,000.00 |
| Dec 31, 2025 | 823,000.00 |
| Sep 30, 2025 | 908,000.00 |
| Sep 30, 2025 | 908,000.00 |
| Jun 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 1.54 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Mar 31, 2025 | 1.68 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Dec 31, 2024 | 2.30 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 2.80 Mn |
| Jun 30, 2024 | 2.80 Mn |
| Mar 31, 2024 | 2.32 Mn |
| Mar 31, 2024 | 2.32 Mn |